Yokoyama K, Terao T, Osawa T
Jpn J Exp Med. 1978 Dec;48(6):511-7.
The binding specificity of bacterial lipopolysaccharide (LPS) was investigated by inhibition experiments of the binding of 3H-labelled Escherichia coli lipopolysaccharide (LPS) AND 3H-labelled Salmonella minnesota R595 glycolipid and lipid A to human erythrocytes using various glycoproteins as inhibitors. PAS-1 glycoprotein and band-3 glycoprotein of human erythrocyte membranes exerted strong inhibitory activity. To characterize membrane receptors for LPS, solubilized membranes of human erythrocytes were subjected to affinity chromatography with an affinity adsorbent prepared by coupling S. minnesota R595 glycolipid to activated Sepharose 4B. Band-3 and PAS-1 glycoproteins were identified as major receptor sites.
通过使用各种糖蛋白作为抑制剂,对3H标记的大肠杆菌脂多糖(LPS)以及3H标记的明尼苏达沙门氏菌R595糖脂和脂质A与人红细胞结合进行抑制实验,研究了细菌脂多糖(LPS)的结合特异性。人红细胞膜的PAS-1糖蛋白和带3糖蛋白具有很强的抑制活性。为了表征LPS的膜受体,将人红细胞的溶解膜用通过将明尼苏达沙门氏菌R595糖脂偶联到活化的琼脂糖4B上制备的亲和吸附剂进行亲和层析。带3糖蛋白和PAS-1糖蛋白被鉴定为主要受体位点。